Security key
71715X203
PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB)
CUSIP: 71715X203
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 3,920,480
- Total 13F value
- $8,791,603
- Share change
- +115,563
- Put/Call ratio
- 1282%
- SEC-reported price per share
- $2.25
- Number of holders
- 24
- Value change
- +$254,010
- Number of buys
- 15
- Number of sells
- 7
- Shares outstanding
- 10,666,413
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
24
Top holders
10
PMCB full security history
Ownership snapshot
Full 13F holder table
PharmaCyte Biotech, Inc. SEC filings
PharmaCyte Biotech, Inc. company facts
PharmaCyte Biotech, Inc. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of PMCB - PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SABBY MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
SABBY MANAGEMENT, LLC
12%
Shay Capital LLC
8.9%
VANGUARD GROUP INC
5.8%
EQUITEC PROPRIETARY MARKETS, LLC
2.9%
GEODE CAPITAL MANAGEMENT, LLC
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
Company
|
12%
|
$2,934,000
1,275,468 shares
|
— | 31 Mar 2022 |
| Shay Capital LLC |
13F
Company
|
8.9%
|
$2,173,000
944,666 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
5.8%
|
$1,414,000
614,625 shares
|
— | 31 Mar 2022 |
| EQUITEC PROPRIETARY MARKETS, LLC |
13F
Company
|
2.9%
|
$711,000
309,294 shares
|
— | 31 Mar 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.6%
|
$394,000
171,523 shares
|
— | 31 Mar 2022 |
| Ayrton Capital LLC |
13F
Company
|
1.4%
|
$352,000
153,130 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
3,920,480
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
19
Q2 2022 holders
24
Holder diff
5
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|